Pancreatic Cancer Research

ResearcherSarah Cannon Research InstituteNo recent work listed

Jeffrey R. Infante

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5059664827, A5103514741. Sources: ClinicalTrials.gov.

Their work

Papers
7 (first author 1, last author 0)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
46
Papers, trials and grants by year

2008: 1 trial · 2009: none · 2010: none · 2011: none · 2012: none · 2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 7

  1. Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC). Co-author DOI 10.1007/s10637-020-01000-6↗
  2. CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitab… Co-author DOI 10.1093/annonc/mdw006↗
  3. Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresect… Co-author DOI 10.1093/annonc/mdw401↗
  4. Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with meta… Co-author DOI 10.1634/theoncologist.2014-0394↗
  5. Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironment. Co-author DOI 10.1155/2014/817613↗
  6. Phase 2, multicenter, open-label study of tigatuzumab (CS-1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in… First author DOI 10.1002/cam4.137↗
  7. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. Co-author DOI 10.1056/nejmoa1304369↗

Trials 1

  1. Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors Principal investigator NCT00743379↗

Closest collaborators

The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Josep M. Tabernero · 3 shared papers, 2013–2016 · strength 0.12
  2. Ramesh K. Ramanathan · 3 shared papers, 2013–2016 · strength 0.12
  3. Elena Gabriela Chiorean · 3 shared papers, 2013–2016 · strength 0.12
  4. Daniel D. Von Hoff · 3 shared papers, 2013–2016 · strength 0.12
  5. Zev A. Wainberg · 1 shared paper, 2021 · strength 0.10
  6. Milind M. Javle · 1 shared paper, 2021 · strength 0.10
  7. Raid M. Aljumaily · 1 shared paper, 2021 · strength 0.10
  8. Manish R. Patel · 1 shared paper, 2021 · strength 0.10
  9. Todd Michael Bauer · 1 shared paper, 2021 · strength 0.10
  10. Joel Randolph Hecht · 1 shared paper, 2021 · strength 0.10
  11. Johanna C. Bendell · 1 shared paper, 2021 · strength 0.10
  12. Shubham Pant · 1 shared paper, 2021 · strength 0.10
  13. Aung Naing · 1 shared paper, 2021 · strength 0.10
  14. David Goldstein · 2 shared papers, 2015–2016 · strength 0.09
  15. Michele Reni · 2 shared papers, 2013–2016 · strength 0.07
  16. Mansoor Noorali Saleh · 2 shared papers, 2013 · strength 0.05
  17. Mitesh J. Borad · 1 shared trial, 2008 · strength 0.05
  18. Andrew H. Ko · 1 shared paper, 2016 · strength 0.05
  19. Volker Kunzmann · 1 shared paper, 2016 · strength 0.05
  20. Joyce F. Liu · 1 shared paper, 2016 · strength 0.04
  21. Brian Matthew Wolpin · 1 shared paper, 2016 · strength 0.04
  22. Howard A. Burris · 1 shared paper, 2016 · strength 0.04
  23. Alfredo Romano · 1 shared paper, 2015 · strength 0.04
  24. Werner Scheithauer · 1 shared paper, 2015 · strength 0.04
  25. Vinod Ganju · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.